PDC*line Pharma receives Advanced-Therapy Medicinal Product classification for its new class of therapeutic cancer vaccines
18-Jun-2015 -
PDC*line Pharma, a clinical-stage biotech company, announces that PDC*vac, its new class of therapeutic cancer vaccines based on a line of Plasmacytoid Dendritic Cells (PDC*line), was granted Advanced-Therapy Medicinal Product (ATMP) classification by the Committee for Advanced Therapies (CAT) of ...
cancer vaccines